These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12505217)

  • 1. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials.
    Cutlip DE; Chauhan MS; Baim DS; Ho KK; Popma JJ; Carrozza JP; Cohen DJ; Kuntz RE
    J Am Coll Cardiol; 2002 Dec; 40(12):2082-9. PubMed ID: 12505217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era.
    Mercado N; Boersma E; Wijns W; Gersh BJ; Morillo CA; de Valk V; van Es GA; Grobbee DE; Serruys PW
    J Am Coll Cardiol; 2001 Sep; 38(3):645-52. PubMed ID: 11527611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular ultrasound predictors of angiographic restenosis in lesions treated with Palmaz-Schatz stents.
    Hoffmann R; Mintz GS; Mehran R; Pichard AD; Kent KM; Satler LF; Popma JJ; Wu H; Leon MB
    J Am Coll Cardiol; 1998 Jan; 31(1):43-9. PubMed ID: 9426016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): immediate and long-term results.
    Rodriguez A; Rodríguez Alemparte M; Fernández Pereira C; Sampaolesi A; da Rocha Loures Bueno R; Vigo F; Obregón A; Palacios IF;
    Am J Med; 2005 Jul; 118(7):743-51. PubMed ID: 15989908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors of restenosis after coronary stent placement.
    Kastrati A; Schömig A; Elezi S; Schühlen H; Dirschinger J; Hadamitzky M; Wehinger A; Hausleiter J; Walter H; Neumann FJ
    J Am Coll Cardiol; 1997 Nov; 30(6):1428-36. PubMed ID: 9362398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct stenting compared to conventional stenting in Diabetic Patients Undergoing Elective Angioplasty for Coronary Artery Disease (DECIDE): a multicenter, open label, randomized, controlled efficacy study.
    Tan HC; Lim YT; Rosli TL; Sim KH; Tan KH; Lee CH; Ismail O; Azman W
    Am Heart J; 2004 Dec; 148(6):1007-11. PubMed ID: 15632886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and angiographic outcomes after use of 90Strontium/90Yttrium beta radiation for the treatment of in-stent restenosis: results from the Stents and Radiation Therapy 40 (START 40) registry.
    Suntharalingam M; Laskey W; Lansky AJ; Waksman R; White L; Teirstien P; Massullo V; Rutherford B; Elman A; Kuntz RE; Popma JJ; Bonan R
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1075-82. PubMed ID: 11958904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and long-term outcome after Palmaz-Schatz stenting: analysis from the New Approaches to Coronary Intervention (NACI) registry.
    Carrozza JP; Schatz RA; George CJ; Leon MB; King SB; Hirshfeld JW; Curry RC; Ivanhoe RJ; Buchbinder M; Cleman MW; Goldberg S; Ricci D; Popma JJ; Safian RD; Baim DS
    Am J Cardiol; 1997 Nov; 80(10A):78K-88K. PubMed ID: 9409695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
    Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
    Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Provisional stenting for multivessel PCI.
    Han B; Liu L; Aboud M; Nahir M; Hasin Y
    Int J Cardiovasc Intervent; 2005; 7(1):46-51. PubMed ID: 16019615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal straightening effect of stents is an additional predictor for major adverse cardiac events. Austrian Wiktor Stent Study Group and European Paragon Stent Investigators.
    Gyöngyösi M; Yang P; Khorsand A; Glogar D
    J Am Coll Cardiol; 2000 May; 35(6):1580-9. PubMed ID: 10807464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled trial of abciximab for prevention of in-stent restenosis in diabetic patients after coronary stenting: results of the ASIAD (Abciximab in Stenting Inhibits restenosis Among Diabetics) Trial.
    Chen WH; Kaul U; Leung SK; Lau YK; Tan HC; Leung AW; Lee MK; Li SK; Ng W; Lee PY; Lam KF; Tse HF; Lau CP
    J Invasive Cardiol; 2005 Oct; 17(10):534-8. PubMed ID: 16204748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of vessel size, lesion length and diabetes mellitus on angiographic restenosis outcomes: insights from the NIRTOP study.
    Kornowski R; Fort S; Almagor Y; Silber S; Lewis BS;
    Acute Card Care; 2008; 10(2):104-10. PubMed ID: 18568572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: a multicenter prospective registry of 150 consecutive patients.
    Di Mario C; Morici N; Godino C; Goktekin O; Tamburino C; Barbagallo R; Antoniucci D; Grube E; Airoldi F; Zoccai GB; Colombo A; Sangiorgi GM
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):416-24. PubMed ID: 17191238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group.
    Erbel R; Haude M; Höpp HW; Franzen D; Rupprecht HJ; Heublein B; Fischer K; de Jaegere P; Serruys P; Rutsch W; Probst P
    N Engl J Med; 1998 Dec; 339(23):1672-8. PubMed ID: 9834304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of the CYPHER Select Sirolimus-eluting stent in the "Real World"--clinical and angiographic results from the China CYPHER Select registry.
    Gao RL; Xu B; Lu SZ; Chen JL; Han YL; Chen JZ; Gai LY; Ge JB; Wang WM; Du ZM; Huo Y; Wang LF; Gao W; Chen JY; He B; Jia GL; Yang ZJ; Cao KJ; Li WM; Shen WF; Wan Z; Huang DJ; Zhu GY;
    Int J Cardiol; 2008 Apr; 125(3):339-46. PubMed ID: 17434617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in patients treated with the zotarolimus-eluting stent at a tertiary medical center.
    Shammas NW; Shammas GA; Lemke J; Miller S; Meriner S
    J Invasive Cardiol; 2012 Jun; 24(6):256-60. PubMed ID: 22684377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): a four-year follow-up.
    Betriu A; Masotti M; Serra A; Alonso J; Fernández-Avilés F; Gimeno F; Colman T; Zueco J; Delcan JL; García E; Calabuig J
    J Am Coll Cardiol; 1999 Nov; 34(5):1498-506. PubMed ID: 10551699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal coronary balloon angioplasty with provisional stenting versus primary stent (OCBAS): immediate and long-term follow-up results.
    Rodríguez A; Ayala F; Bernardi V; Santaera O; Marchand E; Pardiñas C; Mauvecin C; Vogel D; Harrell LC; Palacios IF
    J Am Coll Cardiol; 1998 Nov; 32(5):1351-7. PubMed ID: 9809947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.